Ovoca Bio Plc
A clinical-stage biopharma company developing novel treatments for women's health.
OVXA | IR
Overview
Corporate Details
- ISIN(s):
- IE0006649010 (+1 more)
- LEI:
- 213800ST2AK5XQ1O5207
- Country:
- Ireland
- Address:
- 17 PEMBROKE STREET UPPER, D02 AT22 DUBLIN
- Website:
- https://ovocabio.com/
- Sector:
- Manufacturing
Description
Ovoca Bio is a clinical-stage biopharmaceutical company focused on developing novel treatments for women's health. Its lead product candidate is Orenetide, a treatment for premenopausal women with hypoactive sexual desire disorder (HSDD), a condition characterized by a distressing lack of sexual desire and representing a significant area of high unmet medical need. The company is advancing Orenetide through clinical development for major global markets and has filed for marketing approval in the US and Europe. Ovoca Bio's strategy includes leveraging its patent portfolio and considering licensing or collaboration opportunities to accelerate the availability of its product candidates to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-08-28 09:00 |
Directorate Change
|
English | 12.8 KB | ||
| 2019-08-08 18:14 |
Result of AGM
|
English | 11.8 KB | ||
| 2019-08-08 11:05 |
Second Price Monitoring Extn
|
English | 8.0 KB | ||
| 2019-08-08 11:00 |
Price Monitoring Extension
|
English | 8.0 KB | ||
| 2019-08-08 09:00 |
AGM Statement
|
English | 13.6 KB | ||
| 2019-07-26 09:00 |
Directorate Change
|
English | 13.1 KB | ||
| 2019-07-25 18:41 |
Second Price Monitoring Extn
|
English | 8.0 KB | ||
| 2019-07-25 18:35 |
Price Monitoring Extension
|
English | 8.0 KB | ||
| 2019-06-28 09:00 |
Annual Report and Notice of AGM
|
English | 18.1 KB | ||
| 2019-04-23 09:00 |
US and EU Clinical Development Plans
|
English | 14.2 KB | ||
| 2019-03-27 08:00 |
Operational Update & Additional Investment in IVIX
|
English | 15.9 KB | ||
| 2019-03-25 08:00 |
Primary Endpoints Met in Libicore Phase III Study
|
English | 25.1 KB | ||
| 2018-12-31 08:00 |
Director/PDMR Shareholding
|
English | 30.3 KB | ||
| 2018-09-28 09:00 |
Interim Results
|
English | 17.3 KB | ||
| 2018-09-26 09:00 |
Completion of Acquisition of IVIX
|
English | 13.9 KB |
Automate Your Workflow. Get a real-time feed of all Ovoca Bio Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ovoca Bio Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ovoca Bio Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
